1. Home
  2. GE vs MRK Comparison

GE vs MRK Comparison

Compare GE & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo General Electric Company

GE

General Electric Company

HOLD

Current Price

$321.96

Market Cap

320.8B

Sector

Technology

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$110.66

Market Cap

260.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GE
MRK
Founded
1892
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
320.8B
260.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GE
MRK
Price
$321.96
$110.66
Analyst Decision
Strong Buy
Buy
Analyst Count
10
15
Target Price
$319.30
$115.27
AVG Volume (30 Days)
4.7M
14.3M
Earning Date
01-22-2026
02-03-2026
Dividend Yield
0.46%
3.06%
EPS Growth
31.94
58.08
EPS
7.50
7.56
Revenue
$43,950,000,000.00
$64,235,000,000.00
Revenue This Year
$10.92
$1.98
Revenue Next Year
$11.85
$4.94
P/E Ratio
$41.92
$14.69
Revenue Growth
17.68
1.68
52 Week Low
$159.36
$73.31
52 Week High
$332.79
$112.90

Technical Indicators

Market Signals
Indicator
GE
MRK
Relative Strength Index (RSI) 59.65 72.95
Support Level $310.27 $104.43
Resistance Level $332.79 $112.90
Average True Range (ATR) 6.95 2.19
MACD 0.90 0.30
Stochastic Oscillator 61.34 81.74

Price Performance

Historical Comparison
GE
MRK

About GE General Electric Company

GE Aerospace is the global leader in designing, manufacturing, and servicing commercial aircraft engines, along with partner Safran in their CFM joint venture. With its massive global installed base of nearly 70,000 commercial and military engines, GE Aerospace earns most of its profits on recurring service revenue of that equipment, which operates for decades. GE Aerospace is the remaining core business of the company formed in 1892 with historical ties to American inventor Thomas Edison; that company became a storied conglomerate with peak revenue of $130 billion in 2000 until GE spun off its appliance, finance, healthcare, and wind and power businesses between 2016 and 2024.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: